Post-exposure vaccination improves gammaherpesvirus neutralization

PLoS ONE

Volumn 2, Issue 9, 2007, Pages

  Gillet, Laurent ^a   May, Janet S ^a   Stevenson, Philip G ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; HERPES VACCINE; MONOCLONAL ANTIBODY; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BINDING KINETICS; BONE MARROW CELL; CONTROLLED STUDY; FEMALE; HERPES; HERPES VIRUS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; INFECTION PREVENTION; MEMBRANE FUSION; MOUSE; NONHUMAN; RECEPTOR BLOCKING; VACCINATION; VIRUS CARRIER; VIRUS ENVELOPE; VIRUS NEUTRALIZATION; VIRUS TRANSMISSION; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; FLOW CYTOMETRY; GAMMAHERPESVIRINAE; HAMSTER; IMMUNOLOGY;

HERPESVIRIDAE; MURINAE;

ANIMALS; ANTIBODIES, NEUTRALIZING; CELL LINE; CRICETINAE; FLOW CYTOMETRY; GAMMAHERPESVIRINAE; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; VIRAL VACCINES;

EID: 37149016706     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000899     Document Type: Article

References (43)

1. Tortorella D, Gewurz BE, Furman MH, Schust DJ, Ploegh HL (2000) Viral subversion of the immune system. Annu Rev Immunol 18: 861-926.
2. Yewdell JW, Hill AB (2002) Viral interference with antigen presentation. Nat Immunol 3: 1019-1025.
3. Stevenson PG (2004) Immune evasion by gamma-herpesviruses. Curr Opin Immunol 16: 456-462.
4. Xu J, Lyons PA, Carter MD, Booth TW, Davis-Poynter NJ, et al. (1996) Assessment of antigenicity and genetic variation of glycoprotein B of murine cytomegalovirus. J Gen Virol 77: 49-59.
5. Dingwell KS, Brunetti CR, Hendricks RL, Tang Q, Tang M, et al. (1994) Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. J Virol 68: 834-845.
6. Pecters B, Pol J, Gielkens A, Moormann R (1993) Envelope glycoprotein gp50 of pseudorabies virus is essential for virus entry but is not required for viral spread in mice. J Virol 67: 170-177.
7. Roth MG, Compans RW (1980) Antibody-resistant spread of vesicular stomatitis virus infection in cell lines of epithelial origin. J Virol 35: 547-550.
8. Balachandran N, Bacchetti S, Rawls WE (1982) Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2. Infect Immun 37: 1132-1137.
9. Kohl S, Loo LS, Schmalstieg FS, Anderson DC (1986) The genetic deficiency of leukocyte surface glycoprotein Mac-1, LFA-1, p150,95 in humans is associated with defective antibody-dependent cellular cytotoxicity in vitro and defective protection against herpes simplex virus infection in vivo. J Immunol 137: 1688-1694.
10. Rector JT, Lausch RN, Oakes JE (1982) Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection. Infect Immun 38: 168-174.
11. Huber VC, Lynch JM, Bucher DJ, Le J, Metzger DW (2001) Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections. J Immunol 166: 7381-7388.
12. Johnson DC, Feenstra V (1987) Identification of a novel herpes simplex virus type 1-induced glycoprotein which complexes with gE and binds immunoglobulin. J Virol 61: 2208-2216.
13. Nagashunmugam T, Lubinski J, Wang L, Goldstein LT, Weeks BS, et al. (1998) In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor. J Virol 72: 5351-5359.
14. Stevenson PG, Belz GT, Castrucci MR, Altman JD, Doherty PC (1999) A gamma-herpesvirus sneaks through a CDB(+) T cell response primed to a lytic-phase epitope. Proc Natl Acad Sci U S A 96: 9281-9286.
15. Coleman HM, de Lima B, Morton V, Stevenson PG (2003) Murine gammaherpesvirus 68 lacking thymidine kinase shows severe attenuation of lyric cycle replication in vivo but still establishes latency. J Virol 77: 2410-2417.
16. May JS, Coleman HM, Smillie B, Efstathiou S, Stevenson PG (2004) Forced lytic replication impairs host colonization by a latency-deficient mutant of murine gammaherpesvirus-68. J -Gen Virol 85: 137-146.
17. Rosa GT, Gillet L, Smith CM, de Lima BD, Stevenson PG (2007) IgG fc receptors provide an alternative infection route for murine gamma-herpesvirus-68. PLoS ONE 2: e560.
18. Inada T, Chong KT, Mims CA (1985) Enhancing antibodies, macrophages and virulence in mouse cytomegalovirus infection. J Gen Virol 66: 871-878.
19. Maidji E, McDonagh S, Genbacev O, Tabata T, Pereira L (2006) Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am. J Pathol 168: 1210-1226.
20. Marques S, Efstathiou S, Smith KG, Haury M, Simas JP (2003) Selective gene expression of latent murine gammaherpesvirus 68 in B lymphocytes. J Virol 77: 7308-7318.
21. Gillet L, May JS, Colaco S, Stevenson PG (2007) The murine gammaherpesvirus-68 gp150 acts as an immunogenic decoy to limit virion neutralization. PLoS ONE 2: e705.
22. Gill MB, Gillet L, Colaco S, May JS, de Lima BD, et al. (2006) Murine gammaherpesvirus-68 glycoprotein H-glycoprotein L complex is a major target for neutralizing monoclonal antibodies. J Gen Virol 87: 1465-1475.
23. Belz GT, Stevenson PG, Castrucci MR, Altman JD, Doherty PC (2000) Postexposure vaccination massively increases the prevalence of gammaherpesvirus-specific CD8+ T cells but confers minimal survival advantage on CD4-deficient mice. Proc Natl Acad Sci U S A 97: 2725-2730.
24. de Lima BD, May JS, Stevenson PG (2004) Murine gammaherpesvirus 68 lacking gp150 shows defective virion release but establishes normal latency in vivo. J Virol 78: 5103-5112.
25. Gillet L, Adler H, Stevenson PG (2007) Glycosaminoglycan interactions in murine gammaherpesvirus-68 infection. PLoS ONE 2: e347.
26. Gillet L, May JS, Colaco S, Stevenson PG (2007) Glycoprotein L disruption reveals 2 functional forms of the murine gammaherpesvirus-68 glycoprotein H. J Virol 81: 280-291.
27. Lopes FB, Colaco S, May JS, Stevenson PG (2004) Characterization of the MHV-68 glycoprotein B. J Virol 78: 13370-13375.
28. Gillet L, Gill MB, Colaco S, Smith CM, Stevenson PG (2006) Murine gammaherpesvirus-68 glycoprotein B presents a difficult neutralization target to monoclonal antibodies derived from infected mice. J Gen Virol 87: 3515-3527.
29. Stevenson PG, Doherty PC (1998) Kinetic analysis of the specific host response to a marine gammaherpesvirus. J Virol 72: 943-949.
30. Sangster MY, Topham DJ, D'Costa S, Cardin RD, Marion TN, Myers LK, Doherty, PC (2000) Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus. J Immunol 164: 1820-1828.
31. van Montfort T, Nabatov AA, Geijtenbeek TB, Pollakis G, Paxton WA (2007) Efficient capture of antibody neutralized HIV-1 by cells expressing DC-SIGN and transfer to CD4+ T lymphocytes. J Immunol 178: 3177-3185.
32. Kim IJ, Flano E, Woodland DL, Blackman MA (2002) Antibody-mediated control of persistent gamma-herpesvirus infection. J Immunol 168: 3958-3964.
33. Gangappa S, Kapadia SB, Speck SH, Virgin HW (2002) Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice. J Virol 76: 11460-11468.
34. Niess JH, Brand S, Gu X, Landsman L, Jung S, McCormick BA, Vyas JM, Boes M, Ploegh HL, Fox JG, Littmant DR, Reinecker HC (2005) CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307: 254-258.
35. Bitonti AJ, Dumont JA, Low SC, Peters RT, Kropp KE, Palombella VJ, Stattel JM, Lu Y, Tan CA, Song JJ, Garcia AM, Simister NE, Spiekermann GM, Lencer WI, Blumberg RS (2004) Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway. Proc Natl Acad Sci U S A 101: 9763-9768.
36. Kraehenbuhl JP, Neutra MR (2000) Epithelial M cells: differentiation and function. Annu Rev Cell Dev Biol 16: 301-332.
37. Wang X, Kenyon WJ, Li Q, Mullberg J, Hutt-Fletcher LM (1998) Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells. J Virol 72: 5552-5558.
38. Wang D, Shenk T (2005) Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc Natl Acad Sci USA 102: 18153-18158.
39. Mori Y. Akkapaiboon P. Yonemoto S. Koike M, Takemoto M. Sadaoka T. Sasamoto Y, Konishi S, Uchiyama Y, Yamanishi K (2004) Discovery of a second form of tripartite complex containing gH-gL of human herpesvirus 6 and observations on CD46. J Virol 78: 4609-4616.
40. Jiang R, Scott RS, Hutt-Fletcher LM (2006) Epstein-Barr virus shed in saliva is high in B-cell-tropic glycoprotein gp42. J Virol 80: 7281-7283.
41. Stevenson PG, May JS, Smith XG, Marques S, Adler H, Koszinowski UH, Simas JP, Efstathiou S (2002) K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus. Nat Immunol 3: 733-740.
42. Adler H, Messerle M, Wagner M, Koszinowski UH (2000) Cloning and mutagenesis of the marine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J Virol 74: 6964-6974.
43. Davison AJ, Moss B (1990) New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high level expression of foreign proteins. Nucleic Acids Res 18: 4285-4286.